Amar Gajjar, MD
St. Jude Children's Research Hospital
Find articles about the foundation, medical trials and other pertinent information.
ScienceDaily — A vaccine for treating a recurrent cancer of the central nervous system that occurs primarily in the brain has shown promise in preliminary data from a clinical trial at the University of California, San Francisco.
DCA is an odourless, colourless, inexpensive, relatively non-toxic, small molecule. And researchers at the University of Alberta believe it may soon be used as an effective treatment for many forms of cancer.
Scientists use a synthesized version of poison from a scorpion to treat recurring brain tumors in cancer patients.